HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis.

Abstract
Pancreatic stellate cells (PSCs) play a crucial role in pancreatic fibrogenesis in chronic pancreatitis and in the desmoplastic reaction of pancreatic cancer. When PSCs are stimulated by oxidative stress, ethanol and its metabolite acetaldehyde, and cytokines, the phenotype of quiescent fat-storing cells converts to myofibroblastlike activated PSCs, which then produce extracellular matrix, adhesion molecules, and various chemokines in response to cytokines and growth factors. Recent data suggest that PSCs have a phagocytic function. Plateletderived growth factor is a potent stimulator of PSC proliferation. Transforming growth factor beta, activin A, and connective tissue growth factor also play a role in PSC-mediated pancreatic fibrogenesis through autocrine and paracrine loops. Following pancreatic damage, pathophysiological processes that occur in the pancreas, including pancreas tissue pressure, hyperglycemia, intracellular reactive oxygen species production, activation of protease-activated receptor 2, induction of cyclooxygenase 2, and bacterial infection play a role in sustaining pancreatic fibrosis through increased PSC proliferation and collagen production by PSCs. Targeting PSCs might be an effective therapeutic approach in chronic pancreatitis. Various substances including vitamin A, vitamin E, polyphenols, peroxisome proliferator-activated receptor gamma ligands, and inhibitors of the renin-angiotensin system show great promise of being useful in the treatment of chronic pancreatitis.
AuthorsKyoko Shimizu
JournalJournal of gastroenterology (J Gastroenterol) Vol. 43 Issue 11 Pg. 823-32 ( 2008) ISSN: 0944-1174 [Print] Japan
PMID19012035 (Publication Type: Journal Article, Review)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Antineoplastic Agents
  • Antioxidants
  • Chromans
  • Cytokines
  • Hypoglycemic Agents
  • Protease Inhibitors
  • Thiazolidinediones
  • Vitamins
  • Troglitazone
Topics
  • Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
  • Animals
  • Antineoplastic Agents
  • Antioxidants (therapeutic use)
  • Cell Proliferation
  • Chromans (therapeutic use)
  • Cytokines (metabolism)
  • Fibrosis (etiology, pathology)
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Pancreas (metabolism, pathology)
  • Pancreatitis, Chronic (complications, drug therapy, pathology)
  • Phagocytosis
  • Protease Inhibitors (therapeutic use)
  • Thiazolidinediones (therapeutic use)
  • Troglitazone
  • Vitamins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: